Brookfield to bid $10 billion for Spain's Grifols

Company

Brookfield Asset Management

Law Firm / Organization
Brookfield

Company

Grifols

Law Firm / Organization
Latham & Watkins LLP

Brookfield Asset Management is considering a €7 billion (approximately $10 billion) bid to acquire Grifols, a Spanish pharmaceutical company specializing in blood plasma-based products.

Brookfield is contemplating a public tender offer at €10.5 per share, which is below Grifols' recent market closing price of €11.125.

Grifols has experienced a 30 percent decline in market value since January 2024.

Merger & Acquisition
Healthcare
$ 10,390,520,000
Active